Agenda

Oral Abstracts 1: Cures and Culture: Focus on people who inject drugs

Tracks

Track 2

Monday, August 5, 2019

2:30 PM - 4:00 PM

Endeavour Ballroom 1

Speaker

Associate Professor Alisa Pedrana

Principal Research Fellow

Burnet Institute

THE IMPACT OF COMMUNITY-BASED RAPID POINT OF CARE TESTING ON ENHANCING UPTAKE OF HEPATITIS C TREATMENT FOR PEOPLE WHO INJECT DRUGS IN NEEDLE AND SYRINGE SERVICES.

2:30 PM - 2:45 PM

Abstract

Audio Recording

Presentation

Biography

Attendee86

MAXIMISING ADHERENCE TO DIRECT-ACTING ANTIVIRALS AMONG STREET-BASED AND MARGINALISED CLIENTS: THE RESULTS OF DAILY DOSING

2:45 PM - 3:00 PM

Abstract

Audio Recording

Presentation

Biography

Attendee48

COMMUNITY-BASED HEPATITIS C RECRUITMENT AND TREATMENT FOR PEOPLE WHO INJECT DRUGS AND THEIR INJECTING NETWORK IS FEASIBLE AND EFFECTIVE: THE HCV TREATMENT AND PREVENTION (TAP) STUDY

3:00 PM - 3:15 PM

Abstract

Audio Recording

Biography

Dr Dean Murphy

Senior Research Fellow

ARCSHS, La Trobe University

THE MEANINGS OF INJECTING IN SEXUALISED DRUG-USE SETTINGS AMONG GAY MEN LIVING WITH HIV

3:15 PM - 3:30 PM

Abstract

Audio Recording

Presentation

Biography

Mr Brendan Harney

Post Doctorate Researcher

Burnet Institute

RISK BEHAVIOURS FOLLOWING HEPATITIS C TREATMENT AMONG GAY AND BISEXUAL MEN LIVING WITH HIV IN MELBOURNE, AUSTRALIA

3:30 PM - 3:35 PM

Abstract

Audio Recording

Presentation

Biography

Attendee182

INJECTING CULTURE FOLLOWING PRISON-WIDE HEPATITIS C TREATMENT SCALE-UP: NEGOTIATING RISK AFTER CURE

3:35 PM - 3:40 PM

Abstract

Audio Recording

Presentation

Biography

Dr Behzad Hajarizadeh

Associate Professor

UNSW/ Kirby Institute

HEPATITIS C VIRUS REINFECTION FOLLOWING ANTIVIRAL TREATMENT AMONG PEOPLE WHO USE OR INJECT DRUGS: A SYSTEMATIC REVIEW AND META-ANALYSIS

3:40 PM - 3:45 PM

Abstract

Audio Recording

Presentation

Biography

Attendee233

EXPANDING TESTING AND TREATMENT PROGRAMS FOR HEPATITIS C INTO SECONDARY NEEDLE AND SYRINGE PROGRAMS

3:45 PM - 3:50 PM

Abstract

Audio Recording

Presentation

Biography

Attendee189

IMPACT OF IMPLEMENTATION OF A COLLABORATIVE AND ASSERTIVE HCV FOCUSED MODEL OF CARE ON SCREENING AND TREATMENT UPTAKE, IN A METROPOLITAN, PRIVATE OPIOID PHARMACOTHERAPY CLINIC

3:50 PM - 3:55 PM

Abstract

Audio Recording

Presentation

Biography

Attendee404

COMPARING ADHERENCE TO ONCE-DAILY AND TWICE DAILY DAA THERAPY AMONG PEOPLE WITH RECENT INJECTION DRUG USE OR CURRENT OPIOID SUBSTITUTION THERAPY: THE SIMPLIFY AND D3FEAT STUDIES

3:55 PM - 4:00 PM

Abstract

Audio Recording

Presentation

Biography

Chair

Attendee182

Attendee549